The PHG Foundation has published a new report examining the true potential of AI to deliver genomic medicine. Artificial intelligence for genomic medicine sets out seven policy priorities for decision makers in order to make the best of AI efficiently, while mitigating harms associated with it. The report is free to download from the PHG […]
Through its long-standing partnership with Public Health England (PHE), operationalized by the team of Professor Daniela De Angelis, the MRC Biostatistics Unit (BSU) is involved in the modelling work of the current Covid-19 epidemic that underlies the government’s decisions. Together with groups, including Imperial College, LSHTM, Warwick, Manchester, Exeter, Lancaster, the MRC BSU (Daniela De […]
The University of Cambridge is to take a leading role in a major national effort to help understand and control the new coronavirus infection (COVID-19) announced today by the Government and the UK’s Chief Scientific Adviser.
A logistics centre has been set up by Cambridge University to process donations of personal protective equipment – including face masks, gloves and visors from Cambridge labs – and make it readily available to NHS medics battling the COVID-19 outbreak.
Over the past 70 years richer nations have gradually lost their sense of danger concerning epidemics and serious infections. We must now reacquire this instinctive memory. By Gordon Dougan
Skin cancer is one of the most common cancers in the world, and the incidence is increasing. Could skin cancer detection be transformed by innovative technologies such as digital medicine and artificial intelligence, offering the potential for earlier diagnosis and treatment that could improve survival?
In its recent recommendation on screening for cognitive impairment in older adults, the US Preventive Services Task Force (USPSTF) concludes that “the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults (I statement).”1 This conclusion, supported by an updated evidence report and systematic review,2 is the […]
Having genetically higher testosterone levels increases the risk of metabolic diseases such as type 2 diabetes in women, while reducing the risk in men. Higher testosterone levels also increase the risks of breast and endometrial cancers in women, and prostate cancer in men.
The UK government’s Soft Drinks Industry Levy (SDIL), introduced in April 2018 to help combat childhood obesity and related conditions such as diabetes and heart disease, has resulted in soft drinks manufacturers in the UK lowering the sugar levels in their drinks, researchers have found.
Dr Karen Pinilla is a clinical research fellow at the Cancer Research UK Cambridge Centre. She worked as a clinician in the breast unit at Addenbrooke’s Hospital before starting her fellowship in October 2019. She is now based in both Addenbrooke’s Hospital and the Cancer Research UK Cambridge Institute.